Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survival.

Wang F, Bonam SR, Schall N, Kuhn L, Hammann P, Chaloin O, Madinier JB, Briand JP, Page N, Muller S.

Sci Rep. 2018 Nov 14;8(1):16820. doi: 10.1038/s41598-018-34887-6.

2.

Receptor-ligand and parasite protein-protein interactions in Plasmodium vivax: Analysing rhoptry neck proteins 2 and 4.

Bermúdez M, Arévalo-Pinzón G, Rubio L, Chaloin O, Muller S, Curtidor H, Patarroyo MA.

Cell Microbiol. 2018 Jul;20(7):e12835. doi: 10.1111/cmi.12835. Epub 2018 Mar 26.

PMID:
29488316
3.

Porphyrin Derivatives Inhibit the Interaction between Receptor Activator of NF-κB and Its Ligand.

Chypre M, Madel MB, Chaloin O, Blin-Wakkach C, Morice C, Mueller CG.

ChemMedChem. 2017 Oct 20;12(20):1697-1702. doi: 10.1002/cmdc.201700462. Epub 2017 Oct 4.

PMID:
28885764
4.

Dissecting mechanism of coupled folding and binding of an intrinsically disordered protein by chemical synthesis of conformationally constrained analogues.

Schmidtgall B, Chaloin O, Bauer V, Sumyk M, Birck C, Torbeev V.

Chem Commun (Camb). 2017 Jun 29;53(53):7369-7372. doi: 10.1039/c7cc02276j.

PMID:
28604862
5.

Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier.

Del Rio ML, Bravo Moral AM, Fernandez-Renedo C, Buhler L, Perez-Simon JA, Chaloin O, Alvarez Nogal R, Fernandez-Caso M, Rodriguez-Barbosa JI.

Transl Res. 2017 Mar;181:83-95.e3. doi: 10.1016/j.trsl.2016.09.004. Epub 2016 Sep 15.

PMID:
27702550
6.

Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells.

del Rio ML, Fernandez-Renedo C, Chaloin O, Scheu S, Pfeffer K, Shintani Y, Perez-Simon JA, Schneider P, Rodriguez-Barbosa JI.

MAbs. 2016;8(3):478-90. doi: 10.1080/19420862.2015.1132130. Epub 2016 Jan 11. Erratum in: MAbs. 2016 Nov/Dec;8(8):1620.

7.

Controlled Chemical Derivatisation of Carbon Nanotubes with Imaging, Targeting, and Therapeutic Capabilities.

Ménard-Moyon C, Ali-Boucetta H, Fabbro C, Chaloin O, Kostarelos K, Bianco A.

Chemistry. 2015 Oct 12;21(42):14886-92. doi: 10.1002/chem.201501993. Epub 2015 Sep 2.

PMID:
26331300
8.

Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia.

Al-Ahmady ZS, Chaloin O, Kostarelos K.

J Control Release. 2014 Dec 28;196:332-43. doi: 10.1016/j.jconrel.2014.10.013. Epub 2014 Oct 24.

PMID:
25456832
9.

Therapeutic blockade of LIGHT interaction with herpesvirus entry mediator and lymphotoxin β receptor attenuates in vivo cytotoxic allogeneic responses.

del Rio ML, Fernandez-Renedo C, Scheu S, Pfeffer K, Shintani Y, Kronenberg M, Chaloin O, Schneider P, Rodriguez-Barbosa JI.

Transplantation. 2014 Dec 15;98(11):1165-74. doi: 10.1097/TP.0000000000000417.

10.

Differential modes of peptide binding onto replicative sliding clamps from various bacterial origins.

Wolff P, Amal I, Oliéric V, Chaloin O, Gygli G, Ennifar E, Lorber B, Guichard G, Wagner J, Dejaegere A, Burnouf DY.

J Med Chem. 2014 Sep 25;57(18):7565-76. doi: 10.1021/jm500467a. Epub 2014 Sep 16.

PMID:
25170813
11.

The relationship between the diameter of chemically-functionalized multi-walled carbon nanotubes and their organ biodistribution profiles in vivo.

Wang JT, Fabbro C, Venturelli E, Ménard-Moyon C, Chaloin O, Da Ros T, Methven L, Nunes A, Sosabowski JK, Mather SJ, Robinson MK, Amadou J, Prato M, Bianco A, Kostarelos K, Al-Jamal KT.

Biomaterials. 2014 Nov;35(35):9517-28. doi: 10.1016/j.biomaterials.2014.07.054. Epub 2014 Aug 29.

PMID:
25168822
12.

Adamantane-based dendrons for trimerization of the therapeutic P140 peptide.

Lamanna G, Grillaud M, Macri C, Chaloin O, Muller S, Bianco A.

Biomaterials. 2014 Aug;35(26):7553-61. doi: 10.1016/j.biomaterials.2014.05.017. Epub 2014 Jun 2.

PMID:
24889033
13.

Stereoisomers of 42-hydroxy palytoxin from Hawaiian Palythoa toxica and P. tuberculosa: stereostructure elucidation, detection, and biological activities.

Ciminiello P, Dell'Aversano C, Dello Iacovo E, Forino M, Tartaglione L, Pelin M, Sosa S, Tubaro A, Chaloin O, Poli M, Bignami G.

J Nat Prod. 2014 Feb 28;77(2):351-7. doi: 10.1021/np4009514. Epub 2014 Feb 10.

PMID:
24512352
14.

Dynamic micelles of mannoside glycolipids are more efficient than polymers for inhibiting HIV-1 trans-infection.

Schaeffer E, Dehuyser L, Sigwalt D, Flacher V, Bernacchi S, Chaloin O, Remy JS, Mueller CG, Baati R, Wagner A.

Bioconjug Chem. 2013 Nov 20;24(11):1813-23. doi: 10.1021/bc4000806. Epub 2013 Oct 18.

PMID:
24134734
15.

Sandwich ELISA assay for the quantitation of palytoxin and its analogs in natural samples.

Boscolo S, Pelin M, De Bortoli M, Fontanive G, Barreras A, Berti F, Sosa S, Chaloin O, Bianco A, Yasumoto T, Prato M, Poli M, Tubaro A.

Environ Sci Technol. 2013 Feb 19;47(4):2034-42. doi: 10.1021/es304222t. Epub 2013 Feb 1.

PMID:
23339823
16.

Highly sensitive electrochemiluminescent nanobiosensor for the detection of palytoxin.

Zamolo VA, Valenti G, Venturelli E, Chaloin O, Marcaccio M, Boscolo S, Castagnola V, Sosa S, Berti F, Fontanive G, Poli M, Tubaro A, Bianco A, Paolucci F, Prato M.

ACS Nano. 2012 Sep 25;6(9):7989-97. Epub 2012 Aug 30.

PMID:
22913785
17.

Synthesis of novel mannoside glycolipid conjugates for inhibition of HIV-1 trans-infection.

Dehuyser L, Schaeffer E, Chaloin O, Mueller CG, Baati R, Wagner A.

Bioconjug Chem. 2012 Sep 19;23(9):1731-9. Epub 2012 Aug 7.

PMID:
22871093
18.

Peptide-based approaches to treat lupus and other autoimmune diseases.

Schall N, Page N, Macri C, Chaloin O, Briand JP, Muller S.

J Autoimmun. 2012 Sep;39(3):143-53. doi: 10.1016/j.jaut.2012.05.016. Epub 2012 Jun 22. Review.

PMID:
22727561
19.

HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase.

Lecoeur H, Borgne-Sanchez A, Chaloin O, El-Khoury R, Brabant M, Langonné A, Porceddu M, Brière JJ, Buron N, Rebouillat D, Péchoux C, Deniaud A, Brenner C, Briand JP, Muller S, Rustin P, Jacotot E.

Cell Death Dis. 2012 Mar 15;3:e282. doi: 10.1038/cddis.2012.21.

20.

Reciprocal repression between P53 and TCTP.

Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S, Wynendaele J, Chaloin O, Hoebeke J, Marine JC, Di Fiore PP, Telerman A.

Nat Med. 2011 Dec 11;18(1):91-9. doi: 10.1038/nm.2546.

PMID:
22157679
21.

Selection of a synthetic glycan oligomer from a library of DNA-templated fragments against DC-SIGN and inhibition of HIV gp120 binding to dendritic cells.

Ciobanu M, Huang KT, Daguer JP, Barluenga S, Chaloin O, Schaeffer E, Mueller CG, Mitchell DA, Winssinger N.

Chem Commun (Camb). 2011 Sep 7;47(33):9321-3. doi: 10.1039/c1cc13213j. Epub 2011 Jul 25.

PMID:
21785785
22.

Structure-based design of short peptide ligands binding onto the E. coli processivity ring.

Wolff P, Oliéric V, Briand JP, Chaloin O, Dejaegere A, Dumas P, Ennifar E, Guichard G, Wagner J, Burnouf DY.

J Med Chem. 2011 Jul 14;54(13):4627-37. doi: 10.1021/jm200311m. Epub 2011 Jun 9.

PMID:
21619076
23.

Antibody covalent immobilization on carbon nanotubes and assessment of antigen binding.

Venturelli E, Fabbro C, Chaloin O, Ménard-Moyon C, Smulski CR, Da Ros T, Kostarelos K, Prato M, Bianco A.

Small. 2011 Aug 8;7(15):2179-87. doi: 10.1002/smll.201100137. Epub 2011 May 24.

PMID:
21608125
24.

A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.

Destouches D, Page N, Hamma-Kourbali Y, Machi V, Chaloin O, Frechault S, Birmpas C, Katsoris P, Beyrath J, Albanese P, Maurer M, Carpentier G, Strub JM, Van Dorsselaer A, Muller S, Bagnard D, Briand JP, Courty J.

Cancer Res. 2011 May 1;71(9):3296-305. doi: 10.1158/0008-5472.CAN-10-3459. Epub 2011 Mar 17.

25.

Interaction map of the Trypanosoma cruzi ribosomal P protein complex (stalk) and the elongation factor 2.

Smulski CR, Longhi SA, Ayub MJ, Edreira MM, Simonetti L, Gómez KA, Basile JN, Chaloin O, Hoebeke J, Levin MJ.

J Mol Recognit. 2011 Mar-Apr;24(2):359-70. doi: 10.1002/jmr.1089. Epub 2010 Dec 13.

PMID:
21360618
26.

Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent.

Khiati A, Chaloin O, Muller S, Tardieu M, Horellou P.

J Neurovirol. 2010 Mar;16(2):150-67. doi: 10.3109/13550281003735691.

PMID:
20370601
27.

DNA-templated homo- and heterodimerization of peptide nucleic acid encoded oligosaccharides that mimick the carbohydrate epitope of HIV.

Gorska K, Huang KT, Chaloin O, Winssinger N.

Angew Chem Int Ed Engl. 2009;48(41):7695-700. doi: 10.1002/anie.200903328. No abstract available.

PMID:
19774579
28.

A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice.

Brabant M, Baux L, Casimir R, Briand JP, Chaloin O, Porceddu M, Buron N, Chauvier D, Lassalle M, Lecoeur H, Langonné A, Dupont S, Déas O, Brenner C, Rebouillat D, Muller S, Borgne-Sanchez A, Jacotot E.

Apoptosis. 2009 Oct;14(10):1190-203. doi: 10.1007/s10495-009-0394-y.

PMID:
19693674
29.

Rationally-designed multivalent architectures for mimicking homotrimers of CD40L, a member of the TNF superfamily.

Guichard G, Trouche N, Wieckowski S, Sun W, Chaloin O, Bianco A, Hoebeke J, Schneider P, Fournel S.

Adv Exp Med Biol. 2009;611:355-7. No abstract available.

PMID:
19400224
30.

The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cells.

Page N, Schall N, Strub JM, Quinternet M, Chaloin O, Décossas M, Cung MT, Van Dorsselaer A, Briand JP, Muller S.

PLoS One. 2009;4(4):e5273. doi: 10.1371/journal.pone.0005273. Epub 2009 Apr 23.

31.

Immunomodulatory consequences of ODN CpG-polycation complexes.

Partidos CD, Hoebeke J, Wieckowski S, Chaloin O, Bianco A, Moreau E, Briand JP, Desgranges C, Muller S.

Methods. 2009 Dec;49(4):328-33. doi: 10.1016/j.ymeth.2009.03.005. Epub 2009 Mar 18. Review.

PMID:
19303048
32.

Design and synthesis of intrinsically cell-penetrating nucleopeptides.

Geotti-Bianchini P, Beyrath J, Chaloin O, Formaggio F, Bianco A.

Org Biomol Chem. 2008 Oct 21;6(20):3661-3. doi: 10.1039/b811639c. Epub 2008 Sep 17.

PMID:
18843393
33.

Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat.

Egelé C, Barbier P, Didier P, Piémont E, Allegro D, Chaloin O, Muller S, Peyrot V, Mély Y.

Retrovirology. 2008 Jul 9;5:62. doi: 10.1186/1742-4690-5-62.

34.

The talin rod IBS2 alpha-helix interacts with the beta3 integrin cytoplasmic tail membrane-proximal helix by establishing charge complementary salt bridges.

Rodius S, Chaloin O, Moes M, Schaffner-Reckinger E, Landrieu I, Lippens G, Lin M, Zhang J, Kieffer N.

J Biol Chem. 2008 Aug 29;283(35):24212-23. doi: 10.1074/jbc.M709704200. Epub 2008 Jun 23.

35.

The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro.

Kuciak M, Gabus C, Ivanyi-Nagy R, Semrad K, Storchak R, Chaloin O, Muller S, Mély Y, Darlix JL.

Nucleic Acids Res. 2008 Jun;36(10):3389-400. doi: 10.1093/nar/gkn177. Epub 2008 Apr 28.

36.

Small multivalent architectures mimicking homotrimers of the TNF superfamily member CD40L: delineating the relationship between structure and effector function.

Trouche N, Wieckowski S, Sun W, Chaloin O, Hoebeke J, Fournel S, Guichard G.

J Am Chem Soc. 2007 Nov 7;129(44):13480-92. Epub 2007 Oct 13.

PMID:
17935324
37.

Multifunctionalised cationic fullerene adducts for gene transfer: design, synthesis and DNA complexation.

Klumpp C, Lacerda L, Chaloin O, Da Ros T, Kostarelos K, Prato M, Bianco A.

Chem Commun (Camb). 2007 Sep 28;(36):3762-4. Epub 2007 Jul 5.

PMID:
17851620
38.

Cutting edge: small molecule CD40 ligand mimetics promote control of parasitemia and enhance T cells producing IFN-gamma during experimental Trypanosoma cruzi infection.

Habib M, Noval Rivas M, Chamekh M, Wieckowski S, Sun W, Bianco A, Trouche N, Chaloin O, Dumortier H, Goldman M, Guichard G, Fournel S, Vray B.

J Immunol. 2007 Jun 1;178(11):6700-4.

39.

Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling.

Wieckowski S, Trouche N, Chaloin O, Guichard G, Fournel S, Hoebeke J.

Biochemistry. 2007 Mar 20;46(11):3482-93. Epub 2007 Feb 24.

PMID:
17319699
40.

Mimicking helical antibacterial peptides with nonpeptidic folding oligomers.

Violette A, Fournel S, Lamour K, Chaloin O, Frisch B, Briand JP, Monteil H, Guichard G.

Chem Biol. 2006 May;13(5):531-8.

41.

Design of novel bicyclic analogues derived from a potent oxytocin antagonist.

Flouret G, Chaloin O, Borovickova L, Slaninová J.

J Pept Sci. 2006 Jun;12(6):412-9.

PMID:
16432806
42.

C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L.

Fournel S, Wieckowski S, Sun W, Trouche N, Dumortier H, Bianco A, Chaloin O, Habib M, Peter JC, Schneider P, Vray B, Toes RE, Offringa R, Melief CJ, Hoebeke J, Guichard G.

Nat Chem Biol. 2005 Dec;1(7):377-82.

PMID:
16370373
43.

Analogues of oxytocin antagonists bearing a ureido group in the amino acid side chain at position 4 or 5.

Flouret G, Chaloin O, Borovickova L, Slaninová J.

J Pept Sci. 2006 May;12(5):347-53.

PMID:
16285023
44.

Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity.

Acres B, Gantzer M, Remy C, Futin N, Accart N, Chaloin O, Hoebeke J, Balloul JM, Paul S.

Cancer Res. 2005 Oct 15;65(20):9536-46.

45.

The binding affinity of double-stranded RNA motifs to HIV-1 Tat protein affects transactivation and the neutralizing capacity of anti-Tat antibodies elicited after intranasal immunization.

Partidos CD, Hoebeke J, Moreau E, Chaloin O, Tunis M, Belliard G, Briand JP, Desgranges C, Muller S.

Eur J Immunol. 2005 May;35(5):1521-9.

46.

Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors.

Singh R, Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos CD, Briand JP, Prato M, Bianco A, Kostarelos K.

J Am Chem Soc. 2005 Mar 30;127(12):4388-96.

PMID:
15783221
47.

The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction.

Chaloin O, Peter JC, Briand JP, Masquida B, Desgranges C, Muller S, Hoebeke J.

Cell Mol Life Sci. 2005 Feb;62(3):355-61.

PMID:
15723170
48.

Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties.

Bianco A, Hoebeke J, Godefroy S, Chaloin O, Pantarotto D, Briand JP, Muller S, Prato M, Partidos CD.

J Am Chem Soc. 2005 Jan 12;127(1):58-9.

PMID:
15631447
49.

A synthetic HIV-1 Tat protein breaches the skin barrier and elicits Tat-neutralizing antibodies and cellular immunity.

Partidos CD, Moreau E, Chaloin O, Tunis M, Briand JP, Desgranges C, Muller S.

Eur J Immunol. 2004 Dec;34(12):3723-31.

50.

Supplemental Content

Loading ...
Support Center